Document is current
Any future updates will be listed below
-
Authors
Lantero-Rodriguez, Juan
Camporesi, Elena
Montoliu-Gaya, Laia
Gobom, Johan
Piotrowska, Diana
Olsson, Maria
Burmann, Irena Matečko
Becker, Bruno
Brinkmalm, Ann
Burmann, Björn M.
Perkinton, Michael
Ashton, Nicholas J.
Fox, Nick C.
Lashley, Tammaryn
Zetterberg, Henrik
Blennow, Kaj
Brinkmalm, Gunnar https://orcid.org/0000-0001-6958-2393
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 20 December 2023
Accepted: 26 June 2024
First Online: 19 July 2024
Declarations
:
: Human brain tissues were used in accordance with the Helsinki declaration and the regional ethics committees at UCL and the University of Gothenburg.
: All authors have given their consent for publication.
: HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a cofounder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. NCF has served scientific advisory boards and/or as a consultant for Biogen, Eli Lilly, Ionis and Roche (all payments to UCL) and has been a member of a Data Safety Monitoring Board for Biogen.
